Skip to main content
Equibles
CMCT logo

CMCT · Creative Media & Community Trust Corp · Metrics

Track CMCT — free

Use CMCT with AI

Add company filings, earnings and prices to ChatGPT or Claude, then ask questions in your own chat.

Choose your app for step-by-step connection instructions. Sign in with Equibles when asked; no code or API key is needed.

Claude ChatGPT

After connecting, ask your AI to use Equibles to research CMCT.

Other apps & server URL
https://mcp.equibles.com/mcp
Gemini CLI setup
or ask here

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

See what you can ask in ChatGPT or Claude

All connection guides →
$2.74 -0.08 (-2.84%) At close · Sep 10
Rebalance outlook locked
Customer concentration — top customer 24.3% of revenue

One customer — 24.3% of revenue (the three months ended June 30, 2026)

“Kaiser Foundation Health Plan, Incorporated, which occupied space in one of our Oakland, California properties, accounted for 24.3% of our annualized office rental income for the three months ended June 30, 2026.”
View the 10-Q filed Aug 14, 2026
Market Cap
$8.21M
Shares
2.95M

CMCT metrics

49 of 115 screener metrics currently available.

Open in screener

Market overview

2 metrics
Share price
$2.74
Market cap
$8.21M

Price action

20 metrics
Price change (1W)
-21.4%
Price change (30D)
-39.4%
Price change (3M)
-41.4%
Price change (6M)
—
Price change (YTD)
—
Price change (1Y)
—
Trailing year
Price change (5Y)
—
52-week high
—
52-week low
—
Change from 52-week high
—
Change from 52-week low
—
Annualized volatility
115.6%
Annualized volatility (3M)
107.4%
Beta
—
RSI (14D)
29.7
Price vs SMA 50
-24.0%
Price vs SMA 200
—
Avg volume (3M)
29,873
Relative volume
0.8
Average dollar volume
$113,344

Company

3 metrics
Sector
Real Estate
Industry
REIT - Office
Shares outstanding
2.95M

Valuation

12 metrics
P / E (TTM)
—
Trailing earnings
PEG ratio
—
EV / revenue
4.3×
reciprocal yield 23.0%
EV / EBITDA
—
EV / EBIT
—
P / sales
0.1×
reciprocal yield 1,386.1%
P / book
0.0
reciprocal yield 2,987.9%
FCF yield
—
TTM · current market cap
Buyback yield
—
P / FCF
—
P / operating cash flow
—
Earnings yield
-510.9%

Historical valuation

8 metrics
P / E historical average (3Y)
—
P / E historical average (5Y)
—
EV / revenue historical average (3Y)
4.3×
reciprocal yield 23.4%
EV / revenue historical average (5Y)
4.2×
reciprocal yield 23.9%
EV / EBIT historical average (3Y)
—
EV / EBIT historical average (5Y)
—
EV / EBITDA historical average (3Y)
—
EV / EBITDA historical average (5Y)
—

Dividends & buybacks

7 metrics
Dividend yield
—
Trailing 12 months
Payout ratio
—
Shareholder yield
0.0%
Dividend / share (TTM)
—
Dividend growth YoY
—
Dividend growth streak
—
Last ex-dividend
2024-07-08

Earnings calendar

2 metrics
Next earnings
—
Last earnings
2026-08-14

Profitability

9 metrics
Gross margin
—
Operating margin
—
Trailing 12 months
Net margin
-36.9%
Gross profit (TTM)
—
Operating profit (TTM)
—
Net income (TTM)
−$41.94M
Trailing 12 months
Diluted EPS (TTM)
$-3,014.67
FCF margin
—
Effective tax rate
—

Per share

11 metrics
Revenue per diluted share (TTM)
—
Gross profit per diluted share (TTM)
—
Operating profit per diluted share (TTM)
—
EBITDA per diluted share (TTM)
—
Net income per diluted share (TTM)
—
Operating cash flow per diluted share (TTM)
—
Free cash flow per diluted share (TTM)
—
Capital expenditures per diluted share (TTM)
—
R&D per diluted share (TTM)
—
Stock compensation per diluted share (TTM)
—
Book value per share
$982,927.73

Growth

11 metrics
Revenue growth YoY
0.0%
Year over year
Net income growth YoY
—
Revenue (TTM)
$113.78M
Trailing 12 months
EPS growth YoY
—
Shares change YoY
+33,925.0%
Year over year · more shares
Revenue CAGR (3Y)
+4.6%
Revenue CAGR (5Y)
+8.6%
EPS CAGR (3Y)
—
EPS CAGR (5Y)
—
FCF CAGR (3Y)
—
FCF CAGR (5Y)
—

Quality

14 metrics
Return on equity
-17.1%
Return on assets
-5.4%
Debt / equity
2.0
Current ratio
—
EBITDA (TTM)
—
Free cash flow (TTM)
—
Quick ratio
—
Interest coverage
—
Net debt / EBITDA
—
Return on invested capital
—
Trailing 12 months
Net cash
−$486.00M
Latest balance sheet
Cash & equivalents
$12.77M
Total assets
$782.94M
Total debt
$498.77M

Cash flow & spend

7 metrics
Operating cash flow (TTM)
−$15.48M
Capital expenditures (TTM)
—
R&D (TTM)
—
SG&A (TTM)
—
Stock compensation (TTM)
$238,000
R&D / revenue
—
Stock compensation / revenue
0.2%

Ownership (13F)

3 metrics
13F filers
23
13F filer change QoQ
-20
Institutional ownership
15.5%

Short interest

3 metrics
Short interest
1.5%
Latest settlement · 1.7 days to cover
Days to cover
1.7d
Short-squeeze score
41 / 100

Insider activity

2 metrics
Net insider buying (90D)
—
Insider-sentiment score
—

Risk flags

1 metrics
Going concern
—
Key facts CIK 908311 CUSIP 12564W219 13F (30d) 16 filings 16 filers Visit website Investor relations